Parkway Life Real Estate Investment Trust (PLife REIT), one of Asia’s largest healthcare real estate investment trusts, has announced significant changes to its Board of Directors, effective 20 October 2025. Robin Hu Yee Cheng will take over as Chairman, succeeding Ho Kian Guan, whilst Eng-Kwok Seat Moey joins as an Independent Director, succeeding Cheah Sui Ling as Chairperson of the Audit and Risk Committee.
The appointments are part of a strategic board renewal aimed at reinforcing PLife REIT’s commitment to robust governance and sustainable growth. Robin Hu brings a wealth of experience in investment, sustainability, and digital transformation, having held leadership roles at Milken Institute, Temasek, and Mandai Nature. “I am honoured to take on the role of Board Chairman for the Manager of PLife REIT,” Hu stated, emphasising the importance of building on the solid foundation established by outgoing board members.
Eng-Kwok, recognised for her expertise in capital markets and REITs, will enhance the board’s capability to pursue long-term value creation. Her strategic insight is expected to be instrumental in driving PLife REIT’s future growth.
The board also acknowledges the contributions of retiring members Ho Kian Guan, Jennifer Lee Gek Choo, and Cheah Sui Ling, whose leadership has been pivotal in shaping the trust’s resilience and governance.
With these changes, PLife REIT aims to maintain high standards of corporate governance and transparency, ensuring continued value for its unitholders. The refreshed board composition signals the trust’s readiness to embrace transformative change and reinforce its stature in the healthcare real estate sector.
